Relative transcriptional activities of SAA1 promoters polymorphic at position - 13(T/C): Potential association between increased transcription and amyloidosis

Amyloid

Volumn 12, Issue 1, 2005, Pages 26-32

  Moriguchi, Masato ^a,b   Kaneko, Hirotaka ^a   Terai, Chihiro ^a   Koseki, Yumi ^a   Kajiyama, Hiroshi ^a   Inada, Shinichi ^c   Kitamura, Yutaka ^a   Kamatani, Naoyuki ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b JICHI MEDICAL UNIVERSITY   (Japan)

^c Tokyo Metropolitan Ohtsuka Hospital   (Japan)

Author keywords

AA amyloidosis; Luciferase reporter gene assay; Polymorphism; Serum amyloid A

Indexed keywords

AMYLOID; AMYLOID A PROTEIN; CYTOSINE; LUCIFERASE; THYMINE;

AA AMYLOIDOSIS; AMYLOIDOSIS; ARTICLE; ASIAN; BIOASSAY; CAUCASIAN; CAUCASOID RHEUMATOID ARTHRITIS; DNA FLANKING REGION; FAMILIAL MEDITERRANEAN FEVER; FISHER PROTECTED LEAST SIGNIFICANCE DIFFERENCE TEST; GENE; GENETIC MARKER; GENETIC SUSCEPTIBILITY; GENETIC TRANSCRIPTION; HAPLOTYPE; HUMAN; HUMAN CELL; JAPANESE; LUCIFERASE REPORTER GENE ASSAY; PRIORITY JOURNAL; PROMOTER REGION; REPORTER GENE; RHEUMATOID ARTHRITIS; RISK FACTOR; SAA1 GENE; SAA1.1 GENE; SAA1.3 GENE; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

ALLELES; AMYLOIDOSIS; ARTHRITIS, RHEUMATOID; ASIAN CONTINENTAL ANCESTRY GROUP; CARCINOMA, HEPATOCELLULAR; EUROPEAN CONTINENTAL ANCESTRY GROUP; HAPLOTYPES; HUMANS; LIVER NEOPLASMS; LUCIFERASES; PLASMIDS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); SERUM AMYLOID A PROTEIN; TRANSCRIPTION, GENETIC; TUMOR CELLS, CULTURED;

EID: 21244461521     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.1080/13506120500032394     Document Type: Article

References (26)

1. Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem 1999;265: 501-523.
2. Dewalle M, Domingo C, Rozenbaum M, Ben-Chetrit E, Cattan D, Bernot A, Dross C, Dupont M, Notarnicola C, Levy M, et al. Phenotype-genotype correlation in Jewish patients suffering from familial Mediterranean fever (FMF). Eur J Hum Genet 1998;6:95-97.
3. Cazeneuve C, Sarkisian T, Pecheux C, Dervichian M, Nedelec B, Reinert P, Ayvazyan A, Kouyoumdjian JC, Ajrapetyan H, Delpech M, et al. MEFV-Gene analysis in Armenian patients with Familial Mediterranean fever: diagnostic value and unfavorable renal prognosis of the M694V homozygous genotype-genetic and therapeutic implications. Am J Hum Genet 1999;65:88-97.
4. Shohat M, Magal N, Shohat T, Chen X, Dagan T, Mimouni A, Danon Y, Lotan R, Ogur G, Sirin A, et al. Phenotype-genotype correlation in familial Mediterranean fever: evidence for an association between Met694Val and amyloidosis. Eur J Hum Genet 1999;7:287-292.
5. Livneh A, Langevitz P, Shinar Y, Zaks N, Kastner DL, Pras M, Pras E. MEFV mutation analysis in patients suffering from amyloidosis of familial Mediterranean fever. Amyloid: Int J Exp Clin Invest 1999;6:1-6.
6. Brik R, Shinawi M, Kepten I, Berant M, Gershoni-Baruch R. Familial Mediterranean fever: clinical and genetic characterization in a mixed pediatric population of Jewish and Arab patients. Pediatrics 1999;103:e70.
7. Shinar Y, Livneh A, Langevitz P, Zaks N, Aksentijevich I, Koziol DE, Kastner DL, Pras M, Pras E. Genotype-phenotype assessment of common genotypes among patients with familial Mediterranean fever. J Rheumatol 2000;27: 1703-1707.
8. Gershoni-Baruch R, Brik R, Shinawi M, Livneh A. The differential contribution of MEFV mutant alleles to the clinical profile of familial Mediterranean fever. Eur J Hum Genet 2002;10:145-149.
9. Cazeneuve C, Ajrapetyan H, Papin S, Roudot-Thoraval F, Genevieve D, Mndjoyan E, Papazian M, Sarkisian A, Babloyan A, Boissier B, et al. Identification of MEFV-independent modifying genetic factors for familial Mediterranean fever. Am J Hum Genet 2000;67:1136-1143.
10. Akar N, Hasipek M, Akar E, Ekim M, Yaicinkaya F, Cakar N. Serum amyloid A1 and tumor necrosis factor-alpha alleles in Turkish familial Mediterranean fever patients with and without amyloidosis. Amyloid: J Protein Folding Disord 2003;10:12-16.
11. Gershoni-Baruch R, Brik R, Zacks N, Shinawi M, Lidar M, Livneh A. The contribution of genotypes at the MEFV and SAA1 loci to amyloidosis and disease severity in patients with familial Mediterranean fever. Arthritis Rheum 2003,48:1149-1155.
12. Booth DR, Booth SE, Gillmore JD, Hawkins PN, Pepys MB. SAA1 alleles as risk factors in reactive systemic AA amyloidosis. Amyloid: Int J Exp Clin Invest 1998;5:262-265.
13. Yamada T, Okuda Y, Takasugi K, Wang L, Marks D, Benson MD, Kluve-Beckerman B. An allele of serum amyloid A1 associated with amyloidosis in both Japanese and Caucasians. Amyloid: J Protein Folding Disord 2003;10:7-11.
14. Baba S, Masago SA, Takahashi T, Kasama T, Sugimura H, Tsugane S, Tsutsui Y, Shirasawa H. A novel allelic variant of serum amyloid A, SAA1 gamma: genomic evidence, evolution, frequency, and implication as a risk factor for reactive systemic AA-amyloidosis. Hum Mol Genet 1995;4:1083-1087.
15. Moriguchi M, Terai C, Koseki Y, Uesato M, Nakajima A, Inada S, Nishinarita M, Uchida S, Nakajima A, Kim SY, et al. Influence of genotypes at SAA1 and SAA2 loci on the development and the length of latent period of secondary AA-amyloidosis in patients with rheumatoid arthritis. Hum Genet 1999;105:360-366.
16. Yamada T, Okuda Y, Takasugi K, Itoh K, Igari J. Relative serum amyloid A (SAA) values: the influence of SAA1 genotypes and corticosteroid treatment in Japanese patients with rheumatoid arthritis. Ann Rheum Dis 2001;60:124-127.
17. Moriguchi M, Terai C, Koseki Y, Kaneko H, Uesato M, Nishikawa T, Kamatani N. Genotypes at SAA1 locus correlate with the clinical severity of AA-amyloidosis. Amyloid: J Protein Folding Disord 2001;8:115-120.
18. Moriguchi M, Terai C, Kaneko H, Koseki Y, Kajiyama H, Uesato M, Inada S, Kamatani N. A novel single-nucleotide polymorphism at the 5'-flanking region of SAA1 associated with risk of type AA amyloidosis secondary to rheumatoid arthritis. Arthritis Rheum 2001;44:1266-1272.
19. Kitamura Y, Moriguchi M, Kaneko H, Morisaki H, Morisaki T, Toyama K, Kamatani N. Determination of probability distribution of diplotype configuration (diplotype distribution) for each subject from genotypic data using the EM algorithm. Ann Hum Genet 2002;66:183-193.
20. Kawaguchi Y, Tochimoto A, Ichikawa N, Harigai M, Hara M, Kotake S, Kitamura Y, Kamatani N. Association of IL1A gene polymorphisms with susceptibility to and severity of systemic sclerosis in the Japanese population. Arthritis Rheum 2003;48:186-192.
21. Smith JW, McDonald TL. Production of serum amyloid A and C-reactive protein by HepG2 cells stimulated with combinations of cytokines or monocyte conditioned media: the effects of prednisolone. Clin Exp Immunol 1992;90:293-299.
22. Yamada T, Wada A. Slower clearance of human SAA1.5 in mice: implications for allele specific variation of SAA concentration in human. Amyloid: J Protein Folding Disord 2003;10:147-150.
23. Vallon R, Freuler F, Desta-Tsedu N, Robeva A, Dawson J, Wenner P, Engelhardt P, Boes L, Schnyder J, Tschopp C, et al. Serum amyloid A (apoSAA) expression is up-regulated in rheumatoid arthritis and induces transcription of matrix metalloproteinases. J Immunol 2001;166:2801-2807.
24. Patel H, Fellowes R, Coade S, Woo P. Human serum amyloid A has cytokine-like properties. Scand J Immunol 1998;48: 410-418.
25. Furlaneto CJ, Campa A. A novel function of serum amyloid A: a potent stimulus for the release of tumor necrosis factor-alpha, interleukin-1beta, and interleukin-8 by human blood neutrophil. Biochem Biophys Res Commun 2000;268:405-408.
26. He R, Sang H, Ye RD. Serum amyloid A induces IL-8 secretion through a G protein-coupled receptor, FPRL1/ LXA4R. Blood 2003;101:1572-1581.